![Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice | Journal of Pharmacology and Experimental Therapeutics Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/387/2/188/F8.large.jpg)
Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice | Journal of Pharmacology and Experimental Therapeutics
![Frontiers | The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study Frontiers | The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study](https://www.frontiersin.org/files/Articles/1272177/fped-11-1272177-HTML/image_m/fped-11-1272177-g001.jpg)
Frontiers | The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study
![Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures | Orphanet Journal of Rare Diseases | Full Text Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-020-01353-4/MediaObjects/13023_2020_1353_Fig1_HTML.png)
Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures | Orphanet Journal of Rare Diseases | Full Text
![Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures | Orphanet Journal of Rare Diseases | Full Text Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-020-01353-4/MediaObjects/13023_2020_1353_Fig2_HTML.png)